Biomarker Accelerator Program
Biomarker Accelerator Program supports researchers pursuing biomarker discoveries for progressive supranuclear palsy to accelerate diagnosis, treatment, research, or clinical care.
Browse similar grants
Funder: CurePSP
Due Dates: See program information page
Funding Amounts: See program information page
Summary: Supports biomarker discoveries to accelerate diagnosis, treatment, research, or clinical care for progressive supranuclear palsy (PSP).
Description
CurePSP’s Biomarker Accelerator Program funds projects that drive biomarker discoveries for progressive supranuclear palsy (PSP). Its purpose is to accelerate diagnosis, treatment, research, or clinical care through advances in PSP biomarkers, connecting scientific discovery with improvements in research and care.
The program sits within CurePSP’s broader research mission to advance understanding of PSP and corticobasal degeneration (CBD). That mission includes fundamental neurobiology and mechanisms of disease, as well as translational projects focused on new therapeutics and biomarkers. Within this wider research portfolio, the Biomarker Accelerator Program specifically focuses on PSP biomarker discovery.
